Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Beecham OTC Nicorette labeling contraindicates use of nicotine patches.

Executive Summary

NICORETTE OTC LABELING CONTRAINDICATES USE OF NICOTINE PATCHES and stresses complete cessation of smoking, chewing tobacco or snuff use before beginning the therapy. The label for the SmithKline Beecham product also warns to "ask your doctor before use if you: are under 18 years of age; have heart disease, recent heart attack, or irregular heartbeat...have high blood pressure not controlled with medication...have stomach ulcer or take insulin for diabetes" or "take prescription medicine for depression or asthma."
UsernamePublicRestriction

Register

PS027693

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel